Novo Nordisk (NVO) on Thursday announced plans for a U.S. launch of the Ozempic pill, an oral version of its popular weight ...

A late-stage trial showed that oral semaglutide significantly reduced blood sugar in 10- to 17-year-olds.

PIONEER TEENS is the first clinical trial of an oral GLP-1 RA therapy in children and adolescents aged 10–17 years with type ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Interest surrounding glucagon-like peptide 1 agonists (GLP-1), a class of type 2 diabetes drugs that help ...

Rybelsus (semaglutide) is a brand-name oral tablet that’s prescribed for type 2 diabetes. The cost of the drug with and without insurance can depend on several factors, such as whether Rybelsus has a ...

Rybelsus (semaglutide) is a brand-name prescription medication that doctors prescribe alongside exercise and diet to help improve blood sugar levels in adults with type 2 diabetes. Plans often group ...

Down with Rybelsus! No, this isn’t a line from "1984," but rather the new message from Novo Nordisk for its first Rybelsus ad of 2022. One of the biggest issues facing new medicines like Rybelsus, ...

Add Yahoo as a preferred source to see more of our stories on Google. Ever since being granted approval by the FDA, the prescription injectable medication known as Ozempic has been on the lips of ...

Are you thinking about starting a GLP-1 medication? About 1 in 8 US adults have used GLP-1s to manage diabetes, treat heart disease, or lose weight.  “At this time, there is no other medication like ...